As its competition takes a break, Google is doubling down on video generation through Gemini, with Omni upgrades for it filmmaker and musician-focused Flow AI tools, as well as dedicated mobile apps ...

Macy is a writer on the AI Team. She covers how AI is changing daily life and how to make the most of it. This includes writing about consumer AI products and their real-world impact, from ...

The idea that information should flow freely is deeply embedded in the design of social media. The assumption is that the more information is produced and shared, the better. However, simulations by a ...

Agents have partial observations (lightbulbs) about the state of the world: green or red. Their observations determine their initial beliefs: green-leaning or red-leaning. Agents are randomly paired, ...

If you purchase an independently reviewed product or service through a link on our website, WWD may receive an affiliate commission. Nike‘s new duo of mind-altering shoes have sold out with each drop ...

The Nike Mind shoes have foam nodes on the bottom of the shoe to help activate key pressure points in the brain. Nike Mind pregame mules are $95 while shoes are $145. Whether you're training or in ...

While the underfoot setup of the Fragment Design collaboration appears to feature the same 22-node midsole used on in-line Mind 002 releases, the upper has been completely redesigned, replacing the ...

In an exclusive interview with Hypebeast, the designer shares how she turned her hand to transforming her favorite rum bottle.

The Thor 002 uses a 256 x 192 thermal sensor – its true resolution – and produces a digitally enhanced 512 x 384 image to make thermal maps crisper. Sure, this isn't high-end imaging tech, which you'd ...

Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...

Capsida Biotherapeutics paused the SYNRGY trial for CAP-002 after a participant's death, collaborating with the FDA to investigate the cause and ensure patient safety. The CAP-002 trial, targeting ...

Corina Dutcus, SVP, oncology global clinical development lead, Eisai, highlights how consistent survival data from the LEAP-002 study reaffirms lenvatinib’s value in first-line treatment of ...